Schmutzler C - Search Results

1

Redifferentiation therapy of differentiated thyroid carcinoma with retinoic acid: basics and first clinical results.

Simon D, Köhrle J, Schmutzler C, Mainz K, Reiners C, Röher HD. Simon D, et al. Among authors: schmutzler c. Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:13-5. doi: 10.1055/s-0029-1211692. Exp Clin Endocrinol Diabetes. 1996. PMID: 8980992

2

Effects of retinoids and role of retinoic acid receptors in human thyroid carcinomas and cell lines derived therefrom.

Schmutzler C, Brtko J, Bienert K, Köhrle J. Schmutzler C, et al. Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:16-9. doi: 10.1055/s-0029-1211693. Exp Clin Endocrinol Diabetes. 1996. PMID: 8980993

3

Redifferentiation therapy with retinoids: therapeutic option for advanced follicular and papillary thyroid carcinoma.

Simon D, Koehrle J, Reiners C, Boerner AR, Schmutzler C, Mainz K, Goretzki PE, Roeher HD. Simon D, et al. Among authors: schmutzler c. World J Surg. 1998 Jun;22(6):569-74. doi: 10.1007/s002689900436. World J Surg. 1998. PMID: 9597930

4

Retinoic acid redifferentiation therapy for thyroid cancer.

Schmutzler C, Köhrle J. Schmutzler C, et al. Thyroid. 2000 May;10(5):393-406. doi: 10.1089/thy.2000.10.393. Thyroid. 2000. PMID: 10884186 Review.

5

Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study.

Simon D, Körber C, Krausch M, Segering J, Groth P, Görges R, Grünwald F, Müller-Gärtner HW, Schmutzler C, Köhrle J, Röher HD, Reiners C. Simon D, et al. Among authors: schmutzler c. Eur J Nucl Med Mol Imaging. 2002 Jun;29(6):775-82. doi: 10.1007/s00259-001-0737-6. Epub 2002 Mar 13. Eur J Nucl Med Mol Imaging. 2002. PMID: 12029551 Clinical Trial.

6

Human thyroid carcinoma cell lines show different retinoic acid receptor repertoires and retinoid responses.

Schmutzler C, Hoang-Vu C, Rüger B, Köhrle J. Schmutzler C, et al. Eur J Endocrinol. 2004 Apr;150(4):547-56. doi: 10.1530/eje.0.1500547. Eur J Endocrinol. 2004. PMID: 15080786

7

Implications of the molecular characterization of the sodium-iodide symporter (NIS).

Schmutzler C, Köhrle J. Schmutzler C, et al. Exp Clin Endocrinol Diabetes. 1998;106 Suppl 3:S1-10. doi: 10.1055/s-0029-1212036. Exp Clin Endocrinol Diabetes. 1998. PMID: 9865544 Review.

8

Regulation of CD97 protein in thyroid carcinoma.

Hoang-Vu C, Bull K, Schwarz I, Krause G, Schmutzler C, Aust G, Köhrle J, Dralle H. Hoang-Vu C, et al. Among authors: schmutzler c. J Clin Endocrinol Metab. 1999 Mar;84(3):1104-9. doi: 10.1210/jcem.84.3.5557. J Clin Endocrinol Metab. 1999. PMID: 10084602

9

Increased I-131 uptake in local recurrence and distant metastases after second treatment with retinoic acid.

Koerber C, Schmutzler C, Rendl J, Koehrle J, Griesser H, Simon D, Reiners C. Koerber C, et al. Among authors: schmutzler c. Clin Nucl Med. 1999 Nov;24(11):849-51. doi: 10.1097/00003072-199911000-00005. Clin Nucl Med. 1999. PMID: 10551465

10

The promoter of the human sodium/iodide-symporter gene responds to retinoic acid.

Schmutzler C, Schmitt TL, Glaser F, Loos U, Köhrle J. Schmutzler C, et al. Mol Cell Endocrinol. 2002 Mar 28;189(1-2):145-55. doi: 10.1016/s0303-7207(01)00735-3. Mol Cell Endocrinol. 2002. PMID: 12039073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters